We scoured the nation to identify the best stock in every state. Biogen (symbol BIIB) is the publicly traded company we picked in Massachusetts. The company headquarters is located in Cambridge.
But CFRA analyst Jeffrey Loo believes Biogen is positioned to maintain a leading share in an expanding and diverse market for MS treatments. He projects a slight uptick in revenues from Biogen’s flagship MS drug, Tecfidera, to $4.13 billion this year, up from $3.97 billion in 2016. And Morningstar analyst Karen Andersen has high hopes for Spinraza, a drug aimed at treating spinal muscular atrophy, following recent approvals from the U.S. Food and Drug Administration and the European Union. She sees annual sales of the drug hitting $2 billion by 2020. CFRA’s Loo projects a 23% gain in earnings per share for Biogen in 2017, followed by a 9% increase in 2018. Shares trade at just 13 times Loo’s 2017 earnings estimate, making the stock a good value compared with peers. His 12-month price target of $387 would put Biogen’s shares in line with other biotech firms, says Loo, trading at 18.5 times earnings. That implies a 38% bump from the stock’s current price.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
-
Stock Market Today: Dow Slips After Travelers' Earnings MissThe property and casualty insurer posted a bottom-line miss as catastrophe losses spiked.
-
Stock Market Today: Stocks Stabilize After Powell's Rate-Cut WarningThe main indexes temporarily tumbled after Fed Chair Powell said interest rates could stay higher for longer.
-
Stock Market Today: Stocks Reverse Lower as Treasury Yields SpikeA good-news-is-bad-news retail sales report lowered rate-cut expectations and caused government bond yields to surge.
-
Stock Market Today: Nasdaq Leads as Magnificent 7 Stocks RiseStrength in several mega-cap tech and communication services stocks kept the main indexes higher Thursday.
-
Stock Market Today: Stocks Tumble After a Hot Inflation PrintEquities retreated after inflation data called the Fed's rate-cut plans into question.
-
Stock Market Today: Stocks End Mixed Ahead of Key Inflation ReadingEquities struggled before tomorrow's big Consumer Price Index report.
-
Stock Market Today: Stocks Closed Mixed in Choppy TradingVolatility returned as market participants adjusted their expectations for rate cuts.
-
Stock Market Today: Stocks Rally After Blowout Jobs ReportStocks soared into the weekend as investors brushed off strong payrolls data and lowered rate-cut expectations.
